Related Experiment Videos
Histopathologic findings associated with a chronic, progressive decline in renal allograft function
B L Kasiske1, R S Kalil, H S Lee
1Department of Medicine, University of Minnesota College of Medicine, Minneapolis.
Kidney International
|September 1, 1991
Summary
Histologic findings of chronic rejection (CR) in kidney transplants do not predict the onset of chronic progressive decline in allograft function (CPDAF). However, CR severity correlates with reduced allograft survival duration.
Area of Science:
- Nephrology
- Transplantation Immunology
- Pathology
Background:
- The link between chronic rejection (CR) histology and the clinical trajectory of renal transplant recipients experiencing chronic progressive decline in allograft function (CPDAF) remains unclear.
- Understanding this relationship is crucial for managing long-term graft survival.
Purpose of the Study:
- To investigate the association between specific histopathologic findings of CR and the clinical course of CPDAF in renal transplant recipients.
- To determine if histological features can predict the onset or progression of CPDAF and influence graft survival.
Main Methods:
- Retrospective analysis of 100 renal transplant biopsies from 1978-1982.
- Definition of CPDAF onset and course using regression analysis of serial creatinine clearances.
- Assessment of various histopathologic features including interstitial fibrosis, tubular atrophy, arterial narrowing, and glomerular changes.
Main Results:
- Histologic features of CR (interstitial fibrosis, tubular atrophy, fibrointimal narrowing) were more pronounced after CPDAF onset.
- Interstitial hemorrhage preceded CPDAF, unlike acute cellular rejection findings.
- A composite CR severity score strongly correlated with shorter subsequent allograft survival (r = -0.65, P < 0.001).
- Glomerular size did not differ between patients with or without CPDAF, suggesting limited role of compensatory hypertrophy in CR pathogenesis.
Conclusions:
- Specific histologic findings of CR do not predict the onset of CPDAF.
- Histology does not differentiate between immune or non-immune mediated events in CPDAF.
- The severity of CR histology is a significant predictor of the duration of subsequent allograft survival.